Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses - PubMed (original) (raw)
. 2000 Jun;25(2):195-200.
doi: 10.1038/76061.
S Ghozland, J Chluba, M Martin, H W Matthes, F Simonin, K Befort, C Gavériaux-Ruff, A Dierich, M LeMeur, O Valverde, R Maldonado, B L Kieffer
Affiliations
- PMID: 10835636
- DOI: 10.1038/76061
Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses
D Filliol et al. Nat Genet. 2000 Jun.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Similar articles
- Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
Gackenheimer SL, Suter TM, Pintar JE, Quimby SJ, Wheeler WJ, Mitch CH, Gehlert DR, Statnick MA. Gackenheimer SL, et al. Neuropeptides. 2005 Dec;39(6):559-67. doi: 10.1016/j.npep.2005.09.006. Epub 2005 Nov 9. Neuropeptides. 2005. PMID: 16289278 - Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone.
Cox V, Clarke S, Czyzyk T, Ansonoff M, Nitsche J, Hsu MS, Borsodi A, Tömböly C, Tóth G, Hill R, Pintar J, Kitchen I. Cox V, et al. Neuropharmacology. 2005 Feb;48(2):228-35. doi: 10.1016/j.neuropharm.2004.09.016. Epub 2004 Dec 8. Neuropharmacology. 2005. PMID: 15695161 - Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S, Minami M, Satoh M, Uhl GR, Sora I, Ikeda K. Ide S, et al. Neuropsychopharmacology. 2004 Sep;29(9):1656-63. doi: 10.1038/sj.npp.1300463. Neuropsychopharmacology. 2004. PMID: 15100703 - Opioid receptor types and subtypes: the delta receptor as a model.
Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ, Porreca F. Zaki PA, et al. Annu Rev Pharmacol Toxicol. 1996;36:379-401. doi: 10.1146/annurev.pa.36.040196.002115. Annu Rev Pharmacol Toxicol. 1996. PMID: 8725395 Review. - Opioid receptor genes inactivated in mice: the highlights.
Gavériaux-Ruff C, Kieffer BL. Gavériaux-Ruff C, et al. Neuropeptides. 2002 Apr-Jun;36(2-3):62-71. doi: 10.1054/npep.2002.0900. Neuropeptides. 2002. PMID: 12359497 Review.
Cited by
- Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness.
Secondulfo C, Mazzeo F, Pastorino GMG, Vicidomini A, Meccariello R, Operto FF. Secondulfo C, et al. Int J Mol Sci. 2024 Aug 29;25(17):9407. doi: 10.3390/ijms25179407. Int J Mol Sci. 2024. PMID: 39273354 Free PMC article. Review. - Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies.
Tiwari C, Khan H, Grewal AK, Dhankhar S, Chauhan S, Dua K, Gupta G, Singh TG. Tiwari C, et al. Inflammopharmacology. 2024 Oct;32(5):3037-3056. doi: 10.1007/s10787-024-01526-8. Epub 2024 Aug 20. Inflammopharmacology. 2024. PMID: 39164607 Review. - Genetic mouse models in opioid research: current status and future directions.
Avila-Zozaya M, Zachariou V. Avila-Zozaya M, et al. J Neural Transm (Vienna). 2024 May;131(5):491-494. doi: 10.1007/s00702-024-02762-6. Epub 2024 Mar 4. J Neural Transm (Vienna). 2024. PMID: 38436758 Review. - Immune and metabolic challenges induce changes in pain sensation and related pathways in the hypothalamus.
Rodriguez-Zas SL, Nowak RA, Antonson AM, Rund L, Bhamidi S, Gomez AN, Southey BR, Johnson RW. Rodriguez-Zas SL, et al. Physiol Genomics. 2024 Apr 1;56(4):343-359. doi: 10.1152/physiolgenomics.00134.2023. Epub 2024 Jan 8. Physiol Genomics. 2024. PMID: 38189117 Free PMC article. - The Impact of UFP-512 in Mice with Osteoarthritis Pain: The Role of Hydrogen Sulfide.
Batallé G, Bai X, Balboni G, Pol O. Batallé G, et al. Antioxidants (Basel). 2023 Dec 7;12(12):2085. doi: 10.3390/antiox12122085. Antioxidants (Basel). 2023. PMID: 38136204 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials